These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 18097177

  • 1. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
    Wei RL, Cheng JW, Cai JP.
    Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF, Scholz GH.
    Med Klin (Munich); 2004 Feb 15; 99(2):71-6. PubMed ID: 14963657
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Meta-analysis of methylprednisolone pulse therapy for Graves' ophthalmopathy.
    Gao G, Dai J, Qian Y, Ma F.
    Clin Exp Ophthalmol; 2014 Nov 15; 42(8):769-77. PubMed ID: 24617953
    [Abstract] [Full Text] [Related]

  • 9. Orbital radiation therapy for Graves' ophthalmopathy.
    Ainbinder DJ, Halligan JB.
    Ophthalmology; 2003 Mar 15; 110(3):449; author reply 449-50. PubMed ID: 12623795
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI, Cockerham KP, Turbin RE, Volpe NJ, Kazim M, Douglas RS, Feldon SE.
    J Neuroophthalmol; 2007 Sep 15; 27(3):205-14. PubMed ID: 17895822
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Orbital irradiation for Graves' ophthalmopathy: Is it safe? A long-term follow-up study.
    Wakelkamp IM, Tan H, Saeed P, Schlingemann RO, Verbraak FD, Blank LE, Prummel MF, Wiersinga WM.
    Ophthalmology; 2004 Aug 15; 111(8):1557-62. PubMed ID: 15288988
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Effects of external orbital radiotherapy on the oculomotor muscle in Graves disease].
    Maalouf T, Angioi-Duprez K, Beckendorff V, Malet T, George JL.
    J Fr Ophtalmol; 1996 Aug 15; 19(12):748-54. PubMed ID: 9033899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of combined orbital radiation and systemic steroids in the management of Graves' orbitopathy.
    Kim JW, Han SH, Son BJ, Rim TH, Keum KC, Yoon JS.
    Graefes Arch Clin Exp Ophthalmol; 2016 May 15; 254(5):991-8. PubMed ID: 26876240
    [Abstract] [Full Text] [Related]

  • 20. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
    Sobieraj DM, White CM, Coleman CI.
    Clin Ther; 2008 Aug 15; 30(8):1416-25. PubMed ID: 18803985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.